Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Private equity buys French medical diagnostic service provider Labco for €1.2bn

European private equity firm Cinven has agreed to acquire a significant majority stake in France’s Labco for €1.2bn ($1.3m).

Dispatches from EATRIS Translational Research Conference, Amsterdam

EATRIS: Pharma has a vital role in translational medicine

When translational medicine researchers recognise the need for pharma industry cash but are wary of handing over drug development to for-profit organisations, how can public-private collaborations bridge the culture gap?

DaVita expands renal, diabetes clinical trial services in EU

Specialty CRO DaVita Clinical Research has expanded its clinical trials capabilities in Germany, Poland and Portugal. 

Qiagen launches new bioinformatics platform for clinical testing labs

Sample and assay technology provider Qiagen has launched a bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS). 

Parexel makes fourth upgrade to its randomization and trial supply management service

The fourth generation of enhancements to Parexel’s Randomization and Trial Supply Management (RTSM) service aims to simplify patient randomization and clinical supply management to reduce delivery timelines.

$100m API investment a boost to Gilead's in-house capacity

Sovaldi maker Gilead Sciences has opened a new laboratory and is investing a further $100m (€91m) for API manufacturing at its site in Canada.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...